Found: 79
Select item for more details and to access through your institution.
Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancer.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2024, v. 484, n. 6, p. 1005, doi. 10.1007/s00428-023-03671-x
- By:
- Publication type:
- Article
A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2–expressing salivary gland carcinoma: a pooled analysis of two phase I studies.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 4, p. 434, doi. 10.1093/jjco/hyad181
- By:
- Publication type:
- Article
Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 1, p. 4, doi. 10.1093/jjco/hyac166
- By:
- Publication type:
- Article
Blockade of EGFR Activation Promotes TNF-Induced Lung Epithelial Cell Apoptosis and Pulmonary Injury.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 16, p. 4021, doi. 10.3390/ijms20164021
- By:
- Publication type:
- Article
Rare Nivolumab-associated Super Hyper Progressive Disease in Patients With Advanced Gastric Cancer.
- Published in:
- In Vivo, 2021, v. 35, n. 3, p. 1865, doi. 10.21873/invivo.12449
- By:
- Publication type:
- Article
Effectiveness and safety of eribulin in Japanese patients with HER2-negative, advanced breast cancer: a 2-year post-marketing observational study in a real-world setting.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1540, doi. 10.1007/s10637-019-00890-5
- By:
- Publication type:
- Article
Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 791, doi. 10.1007/s10637-017-0486-4
- By:
- Publication type:
- Article
Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 3, p. 394, doi. 10.1007/s10637-016-0329-8
- By:
- Publication type:
- Article
Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 3, p. 347, doi. 10.1007/s10637-016-0347-6
- By:
- Publication type:
- Article
Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 2, p. 380, doi. 10.1007/s10637-014-0196-0
- By:
- Publication type:
- Article
Inhibition of EGFR, HER2 and HER3 signaling with AZD8931 alone and in combination with paclitaxel: Phase I study in Japanese patients with advanced solid malignancies and advanced breast cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 5, p. 946, doi. 10.1007/s10637-014-0112-7
- By:
- Publication type:
- Article
High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin.
- Published in:
- International Journal of Clinical Oncology, 2011, v. 16, n. 3, p. 244, doi. 10.1007/s10147-010-0170-6
- By:
- Publication type:
- Article
Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0121891
- By:
- Publication type:
- Article
Risk Factors for Cisplatin-Induced Nephrotoxicity and Potential of Magnesium Supplementation for Renal Protection.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101902
- By:
- Publication type:
- Article
Loss of Cytoplasmic CDK1 Predicts Poor Survival in Human Lung Cancer and Confers Chemotherapeutic Resistance.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023849
- By:
- Publication type:
- Article
A high number of PD-L1+ CD14+ monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 337, doi. 10.1007/s00262-020-02686-6
- By:
- Publication type:
- Article
Re: Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors.
- Published in:
- Oncogene, 2003, v. 22, n. 18, p. 2812, doi. 10.1038/sj.onc.1206388
- By:
- Publication type:
- Article
Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4399, doi. 10.3390/cancers13174399
- By:
- Publication type:
- Article
A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 599, doi. 10.1007/s10637-012-9833-7
- By:
- Publication type:
- Article
Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 639, doi. 10.1007/s10637-010-9565-5
- By:
- Publication type:
- Article
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 3, p. 1258, doi. 10.1002/cam4.1995
- By:
- Publication type:
- Article
A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47673-9
- By:
- Publication type:
- Article
Regression of brain metastases from breast cancer with eribulin: a case report.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
- Published in:
- PLoS ONE, 2020, v. 15, n. 1, p. 1, doi. 10.1371/journal.pone.0226707
- By:
- Publication type:
- Article
P-Glycoprotein Is Positively Correlated with p53 Protein Accumulation in Human Colorectal Cancers.
- Published in:
- Cancer Science, 1997, v. 88, n. 8, p. 738, doi. 10.1111/j.1349-7006.1997.tb00445.x
- By:
- Publication type:
- Article
U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation.
- Published in:
- Journal of Clinical Investigation, 2020, v. 130, n. 1, p. 374, doi. 10.1172/JCI126598
- By:
- Publication type:
- Article
Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 5, p. 307, doi. 10.1159/000475879
- By:
- Publication type:
- Article
Lentinula edodes mycelia extract plus adjuvant chemotherapy for breast cancer patients: Results of a randomized study on host quality of life and immune function improvement.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 3, p. 359, doi. 10.3892/mco.2017.1346
- By:
- Publication type:
- Article
Incidence of carnitine deficiency in patients with cancer pain: A pilot study.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 6, n. 3, p. 331, doi. 10.3892/mco.2017.1159
- By:
- Publication type:
- Article
Prospective replication study implicates the catechol-O-methyltransferase Val158Met polymorphism as a biomarker for the response to morphine in patients with cancer.
- Published in:
- Biomedical Reports, 2017, v. 7, n. 4, p. 380, doi. 10.3892/br.2017.963
- By:
- Publication type:
- Article
Induction of preneoplastic lung lesions in guinea pigs by cigarette smoke inhalation and their exacerbation by high dietary levels of vitamins C and E.
- Published in:
- Carcinogenesis, 2005, v. 26, n. 3, p. 605, doi. 10.1093/carcin/bgh341
- By:
- Publication type:
- Article
Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic.
- Published in:
- International Journal of Cancer, 2004, v. 108, n. 1, p. 146, doi. 10.1002/ijc.11528
- By:
- Publication type:
- Article
Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines.
- Published in:
- International Journal of Cancer, 2003, v. 104, n. 2, p. 238, doi. 10.1002/ijc.10921
- By:
- Publication type:
- Article
Clinical Impact of Switching to a Second EGFR-TKI After a Severe AE Related to a First EGFR-TKI in EGFR-mutated NSCLC.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 6, p. 528, doi. 10.1093/jjco/hys042
- By:
- Publication type:
- Article
A Phase I Study of Gemcitabine Plus Irinotecan for Advanced NSCLC: Japan Clinical Oncology Group Trial (JCOG9904).
- Published in:
- Japanese Journal of Clinical Oncology, 2010, v. 40, n. 10, p. 992, doi. 10.1093/jjco/hyq079
- By:
- Publication type:
- Article
Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer.
- Published in:
- 2001
- By:
- Publication type:
- journal article
High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer.
- Published in:
- International Journal of Oncology, 2021, v. 58, n. 1, p. 57
- By:
- Publication type:
- Article
BRCAness as a prognostic indicator in patients with early breast cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-78016-8
- By:
- Publication type:
- Article
Novel Anti-FOLR1 Antibody–Drug Conjugate MORAb-202 in Breast Cancer and Non-Small Cell Lung Cancer Cells.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 1, p. 6, doi. 10.3390/antib10010006
- By:
- Publication type:
- Article
[fam‐] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on HER2 amplification.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 12, p. 3414, doi. 10.1002/ijc.32408
- By:
- Publication type:
- Article
DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.
- Published in:
- International Journal of Cancer, 2017, v. 141, n. 8, p. 1682, doi. 10.1002/ijc.30870
- By:
- Publication type:
- Article
Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies.
- Published in:
- Biomedicines, 2021, v. 9, n. 12, p. 1929, doi. 10.3390/biomedicines9121929
- By:
- Publication type:
- Article
Diverse Mechanisms of Resistance against Osimertinib, a Third-Generation EGFR-TKI, in Lung Adenocarcinoma Cells with an EGFR -Activating Mutation.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 14, p. N.PAG, doi. 10.3390/cells11142201
- By:
- Publication type:
- Article
Expectation of a Decrease in Pain Affects the Prognosis of Pain in Cancer Patients: a Prospective Cohort Study of Response to Morphine.
- Published in:
- International Journal of Behavioral Medicine, 2017, v. 24, n. 4, p. 535, doi. 10.1007/s12529-017-9644-5
- By:
- Publication type:
- Article